Form 4: Royalty Pharma Executive George W. Lloyd Reports Changes in Beneficial Ownership

EVP George W. Lloyd reports a charitable donation of RPI US LP Interests, which are exchangeable for Royalty Pharma plc Class A Ordinary Shares.

Summary

• George W. Lloyd, EVP of Investments & CLO at Royalty Pharma plc, filed a Form 4 detailing changes in beneficial ownership.
• The report indicates a charitable donation of 7,920 LP interests in RPI US Partners 2019, LP.
• These LP interests are exchangeable for 79,200 Class A Ordinary Shares of Royalty Pharma plc at a ratio of 10 shares per LP interest.
• The reporting person did not receive any payment in connection with the donation.
• The reporting person directly holds 79,200 Class A Ordinary Shares.
• The reporting person indirectly holds 1,387,340 Class A Ordinary Shares through GWL 2021 G LLC, 986,450 through GWL 2020 G, LLC, 1,626,800 through GWL 2014 G, LLC and 81,730 through GWL 2013 NG, LLC.
• The reporting person and family vehicles controlled by the reporting person hold an additional 1,076,831 Class A Ordinary Shares and ICAI Interests exchangeable into 3,530,000 Class A Ordinary Shares.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing. The charitable donation is a slightly positive event, but overall the document is neutral.

Positives

• The donation of LP interests to charity could be viewed positively from a corporate social responsibility perspective.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The charitable donation may have a slightly positive impact on the company's reputation with stakeholders.

Key Dates